Japan’s PMDA issues GMP Certificate to Lupin’s Mandideep facility
The certificate is valid till September 2024
Lupin announced the receipt of GMP (Good Manufacturing Practice) Certificate from…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Japan
Japan drug price reforms risk hurting investment: Bristol-Myers CEO
The Japanese government made reforms in 2018 that change how its national health system pays for new and innovative drugs
Sun Pharma Announces Regulatory Filing of Tildrakizumab in Japan
Japan is a key market with approximately 430,000 people currently suffering from psoriasis and psoriatic arthritis
Sun Pharma enters Japanese prescription market
Acquires 14 prescription brands
Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to…
Lupin’s subsidiary to set up plant in Japan
Kyowa Pharmaceutical Industry Co will set up the plant at Tottori, as part of expansion plans in the country
Japan’s Daiichi Sankyo sells Sun Pharma stake
Daiichi Sankyo said it would disclose the financial details related to the Sun Pharma stake sale when it announces results for the…